$RHE
Regional Health Properties Inc

2023 Q1 Form 10-K Financial Statement

#000095017023012916 Filed on April 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $3.906M $10.16M $35.93M
YoY Change -41.25% 57.71% 34.6%
Cost Of Revenue $2.537M $6.413M $20.45M
YoY Change 8.28% 175.0% 121.28%
Gross Profit $1.369M $3.742M $15.47M
YoY Change -68.2% -8.89% -11.32%
Gross Profit Margin 35.05% 36.85% 43.07%
Selling, General & Admin $1.512M $2.705M $15.06M
YoY Change -67.84% -6.04% 33.35%
% of Gross Profit 110.45% 72.29% 97.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $510.0K $585.0K $2.404M
YoY Change -16.8% -8.31% -7.22%
% of Gross Profit 37.25% 15.63% 15.54%
Operating Expenses $4.651M $3.855M $42.75M
YoY Change -41.77% 0.92% 77.29%
Operating Profit -$745.0K -$113.0K -$6.822M
YoY Change -44.36% -139.37% -364.62%
Interest Expense $680.0K -$674.0K $2.529M
YoY Change 4.13% 4.17% -5.25%
% of Operating Profit
Other Income/Expense, Net -$1.247M $1.848M -$45.00K
YoY Change -21.47% -623.51% -98.79%
Pretax Income -$1.992M -$2.244M -$6.867M
YoY Change -31.94% 214.73% 503.96%
Income Tax
% Of Pretax Income
Net Earnings -$1.992M -$4.493M -$6.867M
YoY Change -31.94% 579.73% 480.96%
Net Earnings / Revenue -51.0% -44.24% -19.11%
Basic Earnings Per Share -$2.28 -$8.93
Diluted Earnings Per Share -$2.28 -$2.54 -$8.93
COMMON SHARES
Basic Shares Outstanding 1.883M 1.769M 1.776M
Diluted Shares Outstanding 1.862M 1.776M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.803M $843.0K $843.0K
YoY Change -38.19% -87.59% -87.59%
Cash & Equivalents $2.800M $800.0K $843.0K
Short-Term Investments
Other Short-Term Assets $3.511M $3.812M $3.812M
YoY Change -11.65% 8.42% 8.42%
Inventory
Prepaid Expenses
Receivables $2.915M $6.289M $6.289M
Other Receivables $804.0K $1.099M $1.099M
Total Short-Term Assets $10.03M $12.04M $12.04M
YoY Change -18.17% -6.02% -6.02%
LONG-TERM ASSETS
Property, Plant & Equipment $46.11M $46.61M $49.46M
YoY Change -7.04% -7.01% -38.2%
Goodwill $1.585M $1.585M
YoY Change 0.0% 0.0%
Intangibles $12.17M $12.28M
YoY Change -3.48% -3.45%
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $55.92M $56.54M $56.54M
YoY Change -38.07% -39.13% -39.13%
TOTAL ASSETS
Total Short-Term Assets $10.03M $12.04M $12.04M
Total Long-Term Assets $55.92M $56.54M $56.54M
Total Assets $65.95M $68.58M $68.58M
YoY Change -35.69% -35.12% -35.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.159M $3.293M $3.293M
YoY Change -29.89% -12.16% -12.16%
Accrued Expenses $5.254M $5.036M $5.036M
YoY Change 5.84% 0.98% 0.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.413M $8.329M $8.329M
YoY Change -11.16% -4.66% -4.66%
LONG-TERM LIABILITIES
Long-Term Debt $51.51M $52.18M $52.18M
YoY Change -2.58% -1.32% -1.32%
Other Long-Term Liabilities $4.222M $4.357M $4.357M
YoY Change -87.08% -87.07% -87.07%
Total Long-Term Liabilities $51.51M $52.18M $56.54M
YoY Change -2.58% -1.32% -34.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.413M $8.329M $8.329M
Total Long-Term Liabilities $51.51M $52.18M $56.54M
Total Liabilities $64.15M $64.86M $64.86M
YoY Change -32.49% -31.94% -31.94%
SHAREHOLDERS EQUITY
Retained Earnings -$123.4M -$121.4M
YoY Change 6.0%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.805M $3.716M $3.716M
YoY Change
Total Liabilities & Shareholders Equity $65.95M $68.58M $68.58M
YoY Change -35.69% -35.12% -35.12%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$1.992M -$4.493M -$6.867M
YoY Change -31.94% 579.73% 480.96%
Depreciation, Depletion And Amortization $510.0K $585.0K $2.404M
YoY Change -16.8% -8.31% -7.22%
Cash From Operating Activities $2.600M -$1.425M -$3.596M
YoY Change -262.5% -282.23% -173.48%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $98.00K $281.0K
YoY Change -97.5% -2550.0% 128.46%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.000K -$98.00K -$281.0K
YoY Change -97.5% 2350.0% 128.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $46.00K
YoY Change 557.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -685.0K 35.00K -2.062M
YoY Change 1.78% -106.29% -14.62%
NET CHANGE
Cash From Operating Activities 2.600M -1.425M -3.596M
Cash From Investing Activities -2.000K -98.00K -281.0K
Cash From Financing Activities -685.0K 35.00K -2.062M
Net Change In Cash 1.910M -1.488M -5.939M
YoY Change -219.38% -770.27% -224.48%
FREE CASH FLOW
Cash From Operating Activities $2.600M -$1.425M -$3.596M
Capital Expenditures $2.000K $98.00K $281.0K
Free Cash Flow $2.598M -$1.523M -$3.877M
YoY Change -254.64% -293.77% -181.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Lessor Operating Lease Existence Of Option To Extend
LessorOperatingLeaseExistenceOfOptionToExtend
true
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 rhe Variable Rent Recognized And Collected
VariableRentRecognizedAndCollected
900000
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Lessor Operating Lease Existence Of Option To Extend
LessorOperatingLeaseExistenceOfOptionToExtend
true
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001004724
CY2018Q4 us-gaap Lessor Operating Lease Existence Of Option To Extend
LessorOperatingLeaseExistenceOfOptionToExtend
true
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 us-gaap Lessor Operating Lease Existence Of Option To Extend
LessorOperatingLeaseExistenceOfOptionToExtend
true
CY2018Q4 us-gaap Lessor Operating Lease Existence Of Option To Extend
LessorOperatingLeaseExistenceOfOptionToExtend
true
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-33135
CY2022 dei Entity Registrant Name
EntityRegistrantName
Regional Health Properties, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-5166048
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
454 Satellite Boulevard NW
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Suwanee
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30024-7191
CY2022 dei City Area Code
CityAreaCode
678
CY2022 dei Local Phone Number
LocalPhoneNumber
869-5116
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
6590.598
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1883028
CY2022 dei Auditor Firm
AuditorFirmId
677
CY2022 dei Auditor Name
AuditorName
Cherry Bekaert LLP
CY2022 dei Auditor Location
AuditorLocation
Atlanta, Georgia
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46611000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50127000
CY2022Q4 us-gaap Cash
Cash
843000
CY2021Q4 us-gaap Cash
Cash
6792000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
3066000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
3056000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1298000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
177000
CY2022Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
6289000
CY2021Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
2145000
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
746000
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
460000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1099000
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
362000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
110000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
134000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2848000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29909000
CY2022Q4 us-gaap Goodwill
Goodwill
1585000
CY2021Q4 us-gaap Goodwill
Goodwill
1585000
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
398000
CY2022Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
2912000
CY2021Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
8257000
CY2022Q4 us-gaap Assets
Assets
68580000
CY2021Q4 us-gaap Assets
Assets
105696000
CY2022Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
45163000
CY2021Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
46043000
CY2022Q4 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
6120000
CY2021Q4 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
6239000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
895000
CY2021Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
594000
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3293000
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3749000
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
5036000
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
4987000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3226000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
32059000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
1131000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1629000
CY2022Q4 us-gaap Liabilities
Liabilities
64864000
CY2021Q4 us-gaap Liabilities
Liabilities
95300000
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1794000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1775000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1775000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1775000
CY2022Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
62702000
CY2021Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
62515000
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2021Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2812000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2812000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2812000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2812000
CY2022Q4 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
70288000
CY2021Q4 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
70288000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
62423000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
62423000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121409000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-114542000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3716000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10396000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68580000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
105696000
CY2022 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
12794000
CY2021 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
16093000
CY2022 us-gaap Revenues
Revenues
35925000
CY2021 us-gaap Revenues
Revenues
26690000
CY2022 rhe Patient Care Expense
PatientCareExpense
20453000
CY2021 rhe Patient Care Expense
PatientCareExpense
9243000
CY2022 rhe Facility Rent Expense
FacilityRentExpense
4876000
CY2021 rhe Facility Rent Expense
FacilityRentExpense
6464000
CY2022 rhe Cost Of Management Fees
CostOfManagementFees
619000
CY2021 rhe Cost Of Management Fees
CostOfManagementFees
672000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2404000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2591000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4652000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3931000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4916000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
182000
CY2022 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-1417000
CY2022 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-1436000
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1974000
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1074000
CY2022 us-gaap Operating Expenses
OperatingExpenses
42747000
CY2021 us-gaap Operating Expenses
OperatingExpenses
24157000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-6822000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
2533000
CY2022 us-gaap Interest Expense
InterestExpense
2529000
CY2021 us-gaap Interest Expense
InterestExpense
2669000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-452000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
146000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2936000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1192000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-45000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3715000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-6867000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1182000
CY2022 rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
8997000
CY2021 rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
8997000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15864000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10179000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.93
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.93
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.87
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.87
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1776000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1776000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1734000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1734000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11104000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
481000
CY2021 rhe Stock Issued During Period Value Exercises Of Options And Warrants
StockIssuedDuringPeriodValueExercisesOfOptionsAndWarrants
-7000
CY2021 us-gaap Profit Loss
ProfitLoss
-1182000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10396000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
233000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-46000
CY2022 us-gaap Profit Loss
ProfitLoss
-6867000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3716000
CY2022 us-gaap Profit Loss
ProfitLoss
-6867000
CY2021 us-gaap Profit Loss
ProfitLoss
-1182000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2404000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2591000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
233000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
481000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
122000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
7000
CY2022 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-425000
CY2021 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-2687000
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
86000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
97000
CY2022 rhe Noncash Gains Losses On Extinguishment Of Debt
NoncashGainsLossesOnExtinguishmentOfDebt
-452000
CY2021 rhe Noncash Gains Losses On Extinguishment Of Debt
NoncashGainsLossesOnExtinguishmentOfDebt
146000
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1417000
CY2022 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-1436000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4916000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
182000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6677000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-790000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-197000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-932000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-393000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3377000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-497000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
452000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3596000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4894000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
281000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
123000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-281000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-123000
CY2022 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
7778000
CY2022 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
8830000
CY2021 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
2266000
CY2022 rhe Deferred Financing Costs
DeferredFinancingCosts
296000
CY2022 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
718000
CY2021 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
121000
CY2022 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
CY2021 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
21000
CY2022 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
50000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2062000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2415000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5939000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2356000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9848000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7492000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3909000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9848000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2445000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2797000
CY2021 rhe Noncash Payments Of Long Term Debt
NoncashPaymentsOfLongTermDebt
-5044000
CY2021 rhe Non Cash Debt Issuance Costs And Extinguishment Expenses
NonCashDebtIssuanceCostsAndExtinguishmentExpenses
-102000
CY2021 rhe Net Payments Through Lender
NetPaymentsThroughLender
-5146000
CY2021 rhe Noncash Proceeds From Financing
NoncashProceedsFromFinancing
5146000
CY2021 rhe Non Cash Gain On Ppp Loan Forgiveness
NonCashGainOnPPPLoanForgiveness
229000
CY2021 rhe Noncash Or Part Capture Of Security Deposit And Other Payables
NoncashOrPartCaptureOfSecurityDepositAndOtherPayables
38000
CY2022 rhe Reclassification From Accounts Receivable To Notes Receivable
ReclassificationFromAccountsReceivableToNotesReceivable
546000
CY2022 rhe Vendor Financed Insurance
VendorFinancedInsurance
1259000
CY2021 rhe Vendor Financed Insurance
VendorFinancedInsurance
867000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2322000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported results of operations during the reporting period. Significant estimates include the self-insurance reserve for professional and general liability, patient care revenues, allowance for doubtful accounts, contractual allowances for Medicaid, Medicare, and managed care reimbursements, deferred tax valuation allowance, valuation of goodwill and other long-lived assets, and cash flow projections. Actual results could differ materially from those estimates.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain reclassifications have been made to the amounts in prior periods in order to conform to the current period's presentation. These classifications had no impact on net loss or cash flows from operations for the year ended 2022 or 2021.</span></p></div>
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain reclassifications have been made to the amounts in prior periods in order to conform to the current period's presentation. These classifications had no impact on net loss or cash flows from operations for the year ended 2022 or 2021.</span></p>
CY2022 rhe Percentage Of Revenue Recognized From Government Sources
PercentageOfRevenueRecognizedFromGovernmentSources
0.90
CY2022Q4 rhe Penalty For Service Contract Non Performance
PenaltyForServiceContractNonPerformance
50000
CY2022Q4 rhe Percentage Of Reserve For Patient Care Receivables
PercentageOfReserveForPatientCareReceivables
0.015
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6300000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2100000
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
7587000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1298000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
177000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6289000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2145000
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments which potentially expose the Company to concentrations of credit risk consist primarily of cash, restricted cash, accounts receivable and straight-line rent receivables. Cash and restricted cash are held with various financial institutions. From time to time, these balances exceed the federally insured limits. These balances are maintained with high quality financial institutions which management believes limits the risk.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable are recorded at net realizable value. The Company performs ongoing evaluations of its tenants and significant third-party payors with which it contracts, and generally does not require collateral. The Company maintains an allowance for doubtful accounts which management believes is sufficient to cover potential losses. Delinquent accounts receivable are charged against the allowance for doubtful accounts once collection has been determined to be unlikely. Accounts receivable are considered past due and placed on delinquent status based upon contractual terms as well as how frequently payments are received, on an individual account basis.</span></p>
CY2022 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
391000
CY2021 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
464000
CY2022 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
391000
CY2021 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
464000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
3056000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3909000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9848000
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3293000
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3749000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
1100000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1600000
CY2022Q4 us-gaap Lease Deposit Liability
LeaseDepositLiability
500000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
700000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
500000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68327000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
48000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
56000
CY2022Q4 rhe Antidilutive Securities Excluded From Computation Of Earnings Per Share Intrinsic Value
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareIntrinsicValue
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72965000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21716000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22838000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46611000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50127000
CY2022Q4 us-gaap Land Improvements
LandImprovements
100000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
800000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
52200000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
1100000
CY2022Q4 rhe Long Term Debt Maturities Repayments Of Principal In Next Twelve Months Subject To Non Default In Payments
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsSubjectToNonDefaultInPayments
1800000
CY2022Q4 rhe Number Of Skilled Nursing Facilities
NumberOfSkilledNursingFacilities
3
CY2021 rhe Prior Leases Contracted Cash Rent
PriorLeasesContractedCashRent
2000000.0
CY2022Q4 rhe Number Of Facilities
NumberOfFacilities
5
CY2022Q4 us-gaap Cash
Cash
843000
CY2021Q4 us-gaap Cash
Cash
6792000
CY2022Q4 rhe Pledged Assets Not Separately Reported Other Financial Instrument
PledgedAssetsNotSeparatelyReportedOtherFinancialInstrument
135000
CY2021Q4 rhe Pledged Assets Not Separately Reported Other Financial Instrument
PledgedAssetsNotSeparatelyReportedOtherFinancialInstrument
125000
CY2022Q4 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
2155000
CY2021Q4 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
1914000
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
459000
CY2021Q4 us-gaap Escrow Deposit
EscrowDeposit
700000
CY2022Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2021Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
3066000
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2021 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2022 us-gaap Depreciation
Depreciation
1966000
CY2021 us-gaap Depreciation
Depreciation
2153000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
438000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
438000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2404000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2591000
CY2021Q4 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16953000
CY2021Q4 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4240000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12713000
CY2021Q4 us-gaap Goodwill
Goodwill
1585000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
438000
CY2022Q4 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16953000
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4678000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12275000
CY2022Q4 us-gaap Goodwill
Goodwill
1585000
CY2021 rhe Operating Leases Number Of Skilled Nursing Facilities Leased
OperatingLeasesNumberOfSkilledNursingFacilitiesLeased
9
CY2022Q4 rhe Lessee Operating Lease Liability Future Rental Payments Due Year One
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearOne
648000
CY2022Q4 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year One
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearOne
-54000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
594000
CY2022Q4 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Two
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearTwo
633000
CY2022Q4 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Two
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearTwo
-73000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
560000
CY2022Q4 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Three
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearThree
645000
CY2022Q4 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Three
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearThree
-118000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
527000
CY2022Q4 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Four
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearFour
658000
CY2022Q4 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Four
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearFour
-162000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
496000
CY2022Q4 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Five
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearFive
671000
CY2022Q4 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Five
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearFive
-203000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
468000
CY2022Q4 rhe Lessee Operating Lease Liability Future Rental Payments Due After Year Five
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueAfterYearFive
915000
CY2022Q4 rhe Lessee Operating Lease Accretion Of Lease Liability Due After Year Five
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueAfterYearFive
-334000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
581000
CY2022Q4 rhe Lessee Operating Lease Liability Future Rental Payments
LesseeOperatingLeaseLiabilityFutureRentalPayments
4170000
CY2022Q4 rhe Lessee Operating Lease Accretion Of Lease Liability
LesseeOperatingLeaseAccretionOfLeaseLiability
-944000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3226000
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0798
CY2021 rhe Number Of Leased Or Subleased Facilities
NumberOfLeasedOrSubleasedFacilities
20
CY2021 rhe Operating Leases Number Of Skilled Nursing Facilities Sub Leased
OperatingLeasesNumberOfSkilledNursingFacilitiesSubLeased
8
CY2022 rhe Number Of Leased Or Subleased Facilities
NumberOfLeasedOrSubleasedFacilities
11
CY2022 rhe Number Of Managed Skilled Nursing Facilities
NumberOfManagedSkilledNursingFacilities
8
CY2022 rhe Weighted Average Remaining Lease Term Facilities Lessor
WeightedAverageRemainingLeaseTermFacilitiesLessor
P5Y7M6D
CY2018Q4 us-gaap Lessor Operating Lease Option To Extend
LessorOperatingLeaseOptionToExtend
Each sublease has an initial term of 10 years, with renewal options
CY2018Q4 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P10Y
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
6256000
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
6187000
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
6034000
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
5362000
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
5445000
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
11605000
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
40888000
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
6256000
CY2022Q4 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
539000
CY2021Q4 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
343000
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
2428000
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1391000
CY2022Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
80000
CY2021Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
162000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
210000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
206000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
43000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
192000
CY2022Q4 rhe Medicaid Overpayment Healthcare Services
MedicaidOverpaymentHealthcareServices
169000
CY2021Q4 rhe Medicaid Overpayment Healthcare Services
MedicaidOverpaymentHealthcareServices
1529000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1567000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1164000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5036000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4987000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
53302000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
54178000
CY2022Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1005000
CY2021Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1177000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
119000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
125000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
52178000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
52876000
CY2012Q2 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
6600000
CY2022Q4 rhe Debt Instrument Number Of Credit Related Instruments
DebtInstrumentNumberOfCreditRelatedInstruments
16
CY2022Q4 rhe Long Term Debt Maturities Repayments Of Principal In Rolling Year One
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearOne
1778000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
1578000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
2157000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
8624000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
1425000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
37740000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
53302000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
119000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1005000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
52178000
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022 us-gaap Additional Information About Entitys Reportable Segments
AdditionalInformationAboutEntitysReportableSegments
(i) Real Estate Services, which consists of the leasing and subleasing of long-term care and senior living facilities to third-party tenants, including the Company’s management of three facilities on behalf of third-party owners; and (ii) Healthcare Services, which consists of the operation of the Lumber City, LaGrange, Meadowood, Thomasville, Glenvue and the Tara Facilities.
CY2022 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
12794000
CY2021 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
16093000
CY2022 us-gaap Revenues
Revenues
35925000
CY2021 us-gaap Revenues
Revenues
26690000
CY2022 rhe Patient Care Expense
PatientCareExpense
20453000
CY2021 rhe Patient Care Expense
PatientCareExpense
9243000
CY2022 rhe Facility Rent Expense
FacilityRentExpense
4876000
CY2021 rhe Facility Rent Expense
FacilityRentExpense
6464000
CY2022 rhe Cost Of Management Fees
CostOfManagementFees
619000
CY2021 rhe Cost Of Management Fees
CostOfManagementFees
672000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2404000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2591000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4652000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3931000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4916000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
182000
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1417000
CY2022 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-1436000
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1974000
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1074000
CY2022 us-gaap Operating Expenses
OperatingExpenses
42747000
CY2021 us-gaap Operating Expenses
OperatingExpenses
24157000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-6822000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
2533000
CY2022 us-gaap Interest Expense
InterestExpense
2529000
CY2021 us-gaap Interest Expense
InterestExpense
2669000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-452000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
146000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2936000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1192000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-45000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3715000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-6867000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1182000
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2015Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.050
CY2015Q2 rhe Common Stock Amount Of Common Dividends In Arrears
CommonStockAmountOfCommonDividendsInArrears
50.000
CY2015Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.055
CY2015Q3 rhe Common Stock Amount Of Common Dividends In Arrears
CommonStockAmountOfCommonDividendsInArrears
55.000
CY2015Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.060
CY2015Q4 rhe Common Stock Amount Of Common Dividends In Arrears
CommonStockAmountOfCommonDividendsInArrears
60.000
CY2015 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.165
CY2015 rhe Common Stock Amount Of Common Dividends In Arrears
CommonStockAmountOfCommonDividendsInArrears
165
CY2017Q1 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.68
CY2017Q2 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.68
CY2017Q3 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.68
CY2017Q4 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.68
CY2017Q4 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
1912000
CY2017 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.68
CY2017 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
1912000
CY2018Q1 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.68
CY2018Q1 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
1912000
CY2018Q2 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.68
CY2018Q2 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
1912000
CY2018Q3 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.68
CY2018Q3 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
1912000
CY2018Q4 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2018Q4 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2018 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
2.84
CY2018 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
7985000
CY2019Q1 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2019Q1 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2250000
CY2019Q2 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2019Q2 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2019Q3 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2019Q3 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2019Q4 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2019Q4 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2019 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
3.20
CY2019 rhe Preferred Stock Amount Of Preferred Dividends In Arrears Cumulative Outstanding
PreferredStockAmountOfPreferredDividendsInArrearsCumulativeOutstanding
8997000
CY2020Q1 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2020Q1 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2250000
CY2020Q2 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2020Q2 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2020Q3 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2020Q3 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2020Q4 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2020Q4 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2020 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
3.20
CY2020 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
8997000
CY2021Q1 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2021Q1 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2250000
CY2021Q2 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2021Q2 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2021Q3 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2021Q3 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2021Q4 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2021Q4 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2021 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
3.20
CY2021 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
8997000
CY2022Q1 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2022Q1 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2250000
CY2022Q2 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2022Q2 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2022Q3 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2022Q3 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2022Q4 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.80
CY2022Q4 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
2249000
CY2022 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
3.20
CY2022 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
8997000
CY2022 rhe Preferred Stock Amount Of Preferred Dividends In Arrears Cumulative Outstanding
PreferredStockAmountOfPreferredDividendsInArrearsCumulativeOutstanding
45885000
CY2022 rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
233000
CY2021 rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
481000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
13000
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P1Y7M6D
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
47.53
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
13000
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
47.53
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
35000
CY2022 rhe Class Of Warrant Or Right Exercise Price Range Outstanding Warrants Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightExercisePriceRangeOutstandingWarrantsWeightedAverageRemainingContractualTerm
P1Y10M24D
CY2022 rhe Class Of Warrant And Rights Exercise Price Range Number Of Exercisable Warrants
ClassOfWarrantAndRightsExercisePriceRangeNumberOfExercisableWarrants
35000
CY2022 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
0
CY2021 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
29000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
44000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
192000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
143000
CY2022Q4 rhe Deferred Tax Assets Right Of Use Asset
DeferredTaxAssetsRightOfUseAsset
800000
CY2021Q4 rhe Deferred Tax Assets Right Of Use Asset
DeferredTaxAssetsRightOfUseAsset
7919000
CY2022Q4 rhe Deferred Tax Liabilities Right Of Use Liability
DeferredTaxLiabilitiesRightOfUseLiability
706000
CY2021Q4 rhe Deferred Tax Liabilities Right Of Use Liability
DeferredTaxLiabilitiesRightOfUseLiability
7388000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21127000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
18253000
CY2022Q4 rhe Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
3315000
CY2021Q4 rhe Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
2998000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
175000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
209000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance
20000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance
40000
CY2022Q4 rhe Deferred Tax Assets Deferred Expense Interest Expense
DeferredTaxAssetsDeferredExpenseInterestExpense
1862000
CY2021Q4 rhe Deferred Tax Assets Deferred Expense Interest Expense
DeferredTaxAssetsDeferredExpenseInterestExpense
2300000
CY2022Q4 rhe Deferred Tax Assets Net Of Liabilities Gross
DeferredTaxAssetsNetOfLiabilitiesGross
20184000
CY2021Q4 rhe Deferred Tax Assets Net Of Liabilities Gross
DeferredTaxAssetsNetOfLiabilitiesGross
18522000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20184000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18522000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.022
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.026
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.013
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.017
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.216
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.167
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The Company files federal, state and local income tax returns in the U.S. The Company is generally no longer subject to income tax examinations for years prior to fiscal 2018.

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
rhe-20221231_cal.xml Edgar Link unprocessable
0000950170-23-012916-index-headers.html Edgar Link pending
0000950170-23-012916-index.html Edgar Link pending
0000950170-23-012916.txt Edgar Link pending
0000950170-23-012916-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img134214848_0.jpg Edgar Link pending
img134214848_1.jpg Edgar Link pending
img134214848_2.jpg Edgar Link pending
img134214848_3.jpg Edgar Link pending
img134214848_4.jpg Edgar Link pending
img197642312_0.jpg Edgar Link pending
img63723879_0.jpg Edgar Link pending
img63723879_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rhe-20221231.htm Edgar Link pending
rhe-20221231.xsd Edgar Link pending
rhe-ex10_1d.htm Edgar Link pending
rhe-ex10_1d.pdf Edgar Link pending
rhe-ex10_33c.htm Edgar Link pending
rhe-ex10_33c.pdf Edgar Link pending
rhe-ex10_52a.htm Edgar Link pending
rhe-20221231_def.xml Edgar Link unprocessable
rhe-20221231_lab.xml Edgar Link unprocessable
rhe-20221231_pre.xml Edgar Link unprocessable
rhe-20221231_htm.xml Edgar Link completed
rhe-ex10_52a.pdf Edgar Link pending
rhe-ex10_62.htm Edgar Link pending
rhe-ex10_75.htm Edgar Link pending
rhe-ex10_75.pdf Edgar Link pending
rhe-ex10_83.htm Edgar Link pending
rhe-ex10_83.pdf Edgar Link pending
rhe-ex21_1.htm Edgar Link pending
rhe-ex23_1.htm Edgar Link pending
rhe-ex23_1.pdf Edgar Link pending
rhe-ex31_1.htm Edgar Link pending
rhe-ex31_2.htm Edgar Link pending
rhe-ex32_1.htm Edgar Link pending
rhe-ex32_2.htm Edgar Link pending
Show.js Edgar Link pending